Canadian Manufacturing

AUGUST 10, 2023

a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedelic substances such as MDMA, announces the non-dilutive Debt Financing Agreement and General Security Agreement for proceeds of up to CAD $3,000,000. VANCOUVER — Optimi Health Corp.,

Manufacturing 75

Manufacturing Pharmaceutical Compliance 75

Fabricating & Metal Work

OCTOBER 2, 2023

ABB recently announced an investment of $280 million to expand its manufacturing footprint in Europe and build a new state-of-the-art ABB Robotics European Campus in Västerås, Sweden. Replacing the existing robotics facilities at the site, the new Campus is planned to open in late 2026.

Robotics 52

Robotics Robotics Automation Pharmaceutical 52

Frost & Sullivan Manufacturing

DECEMBER 12, 2022

The company has experienced exponential growth and raised $39 million in January 2022 to increase its organizational capabilities, while the clinical-grade wearables industry is quite a favorable environment for growth as it is expected to grow from $13 billion in 2021 to around $41 billion by 2026.

Pharmaceutical 52

Pharmaceutical 52

Canadian Manufacturing

APRIL 17, 2023

Anand, who is now the defence minister, said they all concluded that Canada’s biomanufacturing capacity “was too limited to justify the investment of capital and expertise to start manufacturing in Canada.” The twelfth one, AbCellera Biologics new manufacturing site, will make antibody therapies.

Manufacturing 40

Manufacturing Supply Chain Pharmaceutical 40

Foley

JULY 11, 2023

Agility and resiliency remain essential attributes for manufacturers in 2023. Manufacturers are no longer focused on figuring out when things will return to “normal.” Most major automobile manufacturers have set aggressive goals to electrify their fleets, many in the range of 40-50% by the mid-2030s.

Manufacturing 40

Manufacturing Compliance Supply Chain Form 40

Manufacturer's Monthly

AUGUST 5, 2024

Image: Pfizer Australia Pfizer Australia has announced a major upgrade to its facility in Melbourne to make it one of the most advanced pharmaceutical production facilities in Australia’s fight against antimicrobial resistance (AMR). We are also pleased to be providing 500 advanced manufacturing jobs at our Melbourne site,” said Harris.

Pharmaceutical 98

Pharmaceutical Artificial Intelligence Advanced manufacturing Manufacturing 98

Frost & Sullivan Manufacturing

MARCH 13, 2025

Click here to download Top Transformations Impacting Growth in Global Molecular Biomarkers Market, Forecast to 2030 Rank Strategic Imperative Category Strategic Imperative Impact Score (%) Timeline Duration Growth Curve 1 Industry Convergence Cross-sector partnerships between pharmaceuticals and AI companies to enhance biomarker precision 72 2025-2039 (..)

Value chain 52

Value chain Pharmaceutical Supply Chain Logistics 52

Robotics Business Review

FEBRUARY 5, 2025

Theres a lot of optimism and a lot of signals right now that 2025, and even into 2026 and 2027, being strong years for automation, Alex Shikany, executive vice president of A3, told The Robot Report last week at Collaborate North America 2025. in units and 0.1% in revenue over 2023. I think there is room to grow in automotive,” he said.

Robotics 58

Robotics Robotics Consumer Goods Automotive 58